- Home
- CARE vs CDTX Comparison
CARE vs CDTX Comparison
Compare CARE & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARE
- CDTX
- Stock Information
- Founded
- CARE 1974
- CDTX 2012
- Country
- CARE United States
- CDTX United States
- Employees
- CARE N/A
- CDTX N/A
- Industry
- CARE Major Banks
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CARE Finance
- CDTX Health Care
- Exchange
- CARE Nasdaq
- CDTX Nasdaq
- Market Cap
- CARE 330.3M
- CDTX 980.1M
- IPO Year
- CARE N/A
- CDTX 2015
- Fundamental
- Price
- CARE $17.79
- CDTX $49.03
- Analyst Decision
- CARE Buy
- CDTX Strong Buy
- Analyst Count
- CARE 2
- CDTX 11
- Target Price
- CARE $21.50
- CDTX $52.11
- AVG Volume (30 Days)
- CARE 113.0K
- CDTX 1.2M
- Earning Date
- CARE 07-24-2025
- CDTX 08-12-2025
- Dividend Yield
- CARE N/A
- CDTX N/A
- EPS Growth
- CARE 111.89
- CDTX N/A
- EPS
- CARE 1.20
- CDTX N/A
- Revenue
- CARE $146,558,000.00
- CDTX $302,000.00
- Revenue This Year
- CARE $10.63
- CDTX N/A
- Revenue Next Year
- CARE $14.34
- CDTX N/A
- P/E Ratio
- CARE $14.46
- CDTX N/A
- Revenue Growth
- CARE 18.52
- CDTX N/A
- 52 Week Low
- CARE $13.61
- CDTX $10.14
- 52 Week High
- CARE $20.40
- CDTX $56.83
- Technical
- Relative Strength Index (RSI)
- CARE 64.84
- CDTX 80.64
- Support Level
- CARE $16.34
- CDTX $45.42
- Resistance Level
- CARE $17.70
- CDTX $50.48
- Average True Range (ATR)
- CARE 0.36
- CDTX 3.98
- MACD
- CARE 0.05
- CDTX 2.40
- Stochastic Oscillator
- CARE 75.32
- CDTX 78.73
About CARE Carter Bankshares Inc.
Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. It offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.